ZYME vs COGT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

ZYME

59.2
AI Score
VS
COGT Wins

COGT

61.8
AI Score

Investment Advisor Scores

ZYME

59score
Recommendation
HOLD

COGT

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZYME COGT Winner
Net Income -81.13M -193.76M ZYME
Operating Income -92.55M -206.25M ZYME
ROE -30.2% -36.4% ZYME
ROA -23.4% -23.2% COGT
Total Assets 346.53M 834.55M COGT
Cash 41.16M 181.17M COGT
Current Ratio 5.88 13.57 COGT
Free Cash Flow -34.53M -164.97M ZYME

Relative Price Performance (Last 90 Days)

ZYME 1M: -19.0% · 3M: -0.7% COGT 1M: -10.3% · 3M: -21.3%

Current Technical Phase

ZYME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.2 · Price: $25.15

COGT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.6%), weak momentum, RSI 35

RSI (14): 35.0 · Price: $31.02

Fundamentals Snapshot

Metric ZYME COGT
Market Cap — —
Forward P/E 28.9 -27.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% -1.0%
Gross Margin -2.5% —
Operating Margin -9.2% 0.0%
EPS -2.02 -2.16
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, COGT is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.